Integra LifeSciences Holdings Corporation held its Annual Meeting of Stockholders on May 9, 2025. Stockholders elected all nominees for the Board of Directors. Additionally, stockholders approved an amendment to the company's Equity Incentive Plan to increase the number of shares available for awards by 2,200,000 shares. The transition of Dr. Stuart M. Essig from Executive Chairman to non-executive Chairman of the Board, effective July 1, 2025, was also confirmed.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000917520-25-000052), on May 13, 2025, and is solely responsible for the information contained therein.